Trial intelligence / Profile preview

Treating Smokeless Tobacco Use in Rural Veterans

NCT02994082Unknown

Start
Dec 2016
Primary completion
Sep 2019
Modality
Transdermal Patches, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of nicotine patch, bupropion and varenicline + nicotine patch in nicotine dependence and smokeless tobacco use (2 arms). Primary endpoint: Treatment satisfaction at 3 months. Status: unknown.

02

Drugs

nicotine patchbupropionvarenicline + nicotine patch
03

Conditions

nicotine dependencesmokeless tobacco use

Beyond the preview

Go deeper on NCT02994082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02994082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call